Purpose of Review Recurrent glioblastoma (rGBM) has no standard treatment. Despite a
better molecular knowledge, few therapies have brought changes in clinical practice so far. …

e19020 Background: Ibrutinib (IBRU) is a Bruton tyrosine kinase (BTK) inhibitor that has been
FDA approved for chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and …

INTRODUCTION: Leptomeningeal metastases (LM) is a devastating complication of cancer.
We previously reported a study of 318 breast cancer (BC) patients with LM with a median …

Background: Pharmaceutical companies play an important role in new drug development
and approval in an environment where performing RCTs has become increasingly costly and …

BACKGROUND Survival benefit with immune checkpoints inhibitors in patients with metastatic
NSCLC and Melanoma has been demonstrated. However, the published results do not …

Ants, an ecologically successful and numerically dominant group of animals, play key ecological
roles as soil engineers, predators, nutrient recyclers, and regulators of plant growth and …

INTRODUCTION: Glioblastoma (GBM) is the most frequent primary malignant tumor from
the central nervous system in adults. However, the presence of systemic metastasis is an …

Opinion statement Primary malignant central nervous (CNS) tumors are a devastating group
of diseases with urgent need for improved treatment options. Surgery, radiation, and …

DISCUSSION Gastro pleural fistula is an uncommon diagnosis. It has been previously
reported as a complication after pulmonary resections, 1 trauma (especially due to traumatic …

INTRODUCTION: Standard treatment for pediatric patients with localized osteosarcoma
includes high-dose methotrexate (HDMTX), and cure rates greater than 60% are observed. …